Annual CAPEX
$1.71 M
-$3.79 M-68.92%
31 December 2023
Summary:
C4 Therapeutics annual capital expenditures is currently $1.71 million, with the most recent change of -$3.79 million (-68.92%) on 31 December 2023. During the last 3 years, it has risen by +$1.06 million (+162.77%). CCCC annual CAPEX is now -68.92% below its all-time high of $5.50 million, reached on 31 December 2022.CCCC CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
-$13.00 K
-$210.00 K-106.60%
30 September 2024
Summary:
C4 Therapeutics quarterly capital expenditures is currently -$13.00 thousand, with the most recent change of -$210.00 thousand (-106.60%) on 30 September 2024. Over the past year, it has dropped by -$613.00 thousand (-102.17%). CCCC quarterly CAPEX is now -100.39% below its all-time high of $3.31 million, reached on 30 September 2022.CCCC Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$341.00 K
-$613.00 K-64.26%
30 September 2024
Summary:
C4 Therapeutics TTM capital expenditures is currently $341.00 thousand, with the most recent change of -$613.00 thousand (-64.26%) on 30 September 2024. Over the past year, it has dropped by -$2.70 million (-88.79%). CCCC TTM CAPEX is now -94.23% below its all-time high of $5.91 million, reached on 31 March 2023.CCCC TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.9% | -102.2% | -88.8% |
| 3 y3 years | +162.8% | -100.0% | -76.6% |
| 5 y5 years | -36.5% | - | - |
CCCC CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -68.9% | +162.8% | -100.4% | at low | -94.2% | at low |
| 5 y | 5 years | -68.9% | +162.8% | -100.4% | +88.1% | -94.2% | +354.7% |
| alltime | all time | -68.9% | +162.8% | -100.4% | +88.1% | -94.2% | +354.7% |
C4 Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.00 K(-106.6%) | $341.00 K(-64.3%) |
| June 2024 | - | $197.00 K(+25.5%) | $954.00 K(-44.1%) |
| Dec 2023 | $1.71 M(-68.9%) | $157.00 K(-73.8%) | $1.71 M(-43.8%) |
| Sept 2023 | - | $600.00 K(+65.7%) | $3.04 M(-47.1%) |
| June 2023 | - | $362.00 K(-38.5%) | $5.75 M(-2.8%) |
| Mar 2023 | - | $589.00 K(-60.5%) | $5.91 M(+7.6%) |
| Dec 2022 | $5.50 M(+330.4%) | $1.49 M(-54.9%) | $5.50 M(+33.6%) |
| Sept 2022 | - | $3.31 M(+524.8%) | $4.12 M(+408.0%) |
| June 2022 | - | $529.00 K(+207.6%) | $810.00 K(-21.2%) |
| Mar 2022 | - | $172.00 K(+57.8%) | $1.03 M(-19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.28 M(+96.5%) | $109.00 K(>+9900.0%) | $1.28 M(-12.5%) |
| Sept 2021 | - | $0.00(-100.0%) | $1.46 M(-16.3%) |
| June 2021 | - | $747.00 K(+77.4%) | $1.74 M(+96.5%) |
| Mar 2021 | - | $421.00 K(+44.7%) | $887.00 K(+36.5%) |
| Dec 2020 | $650.00 K(-51.8%) | $291.00 K(+2.5%) | $650.00 K(+81.1%) |
| Sept 2020 | - | $284.00 K(-360.6%) | $359.00 K(+378.7%) |
| June 2020 | - | -$109.00 K(-159.2%) | $75.00 K(-59.2%) |
| Mar 2020 | - | $184.00 K | $184.00 K |
| Dec 2019 | $1.35 M(-49.8%) | - | - |
| Dec 2018 | $2.69 M | - | - |
FAQ
- What is C4 Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for C4 Therapeutics?
- What is C4 Therapeutics annual CAPEX year-on-year change?
- What is C4 Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for C4 Therapeutics?
- What is C4 Therapeutics quarterly CAPEX year-on-year change?
- What is C4 Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for C4 Therapeutics?
- What is C4 Therapeutics TTM CAPEX year-on-year change?
What is C4 Therapeutics annual capital expenditures?
The current annual CAPEX of CCCC is $1.71 M
What is the all time high annual CAPEX for C4 Therapeutics?
C4 Therapeutics all-time high annual capital expenditures is $5.50 M
What is C4 Therapeutics annual CAPEX year-on-year change?
Over the past year, CCCC annual capital expenditures has changed by -$3.79 M (-68.92%)
What is C4 Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of CCCC is -$13.00 K
What is the all time high quarterly CAPEX for C4 Therapeutics?
C4 Therapeutics all-time high quarterly capital expenditures is $3.31 M
What is C4 Therapeutics quarterly CAPEX year-on-year change?
Over the past year, CCCC quarterly capital expenditures has changed by -$613.00 K (-102.17%)
What is C4 Therapeutics TTM capital expenditures?
The current TTM CAPEX of CCCC is $341.00 K
What is the all time high TTM CAPEX for C4 Therapeutics?
C4 Therapeutics all-time high TTM capital expenditures is $5.91 M
What is C4 Therapeutics TTM CAPEX year-on-year change?
Over the past year, CCCC TTM capital expenditures has changed by -$2.70 M (-88.79%)